AzTrials
AzTrials

SplintsNCT07290348

Effect of Dynamic Hand Splint on Hand ROM Post Extensor Tendon Repair

A study testing customized dynamic hand splint, traditional treatment (first stage) and traditional treatment (second and third stage) in people with Splints and Range of Motion, run by Cairo University at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of the study was to evaluate the effectiveness of dynamic hand splint on hand range of motion following extensor tendon repair. Read more about this study

Who is it for?
Ages 20 to 40 years
What is being tested?
customized dynamic hand splint, traditional treatment (first stage) and traditional treatment (second and third stage)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
40 participants
Where
1 siteEgypt
Study dates
1 Aug 2023to 1 Jan 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 40 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • Patients are both males and females.
  • Their age will be in the range of 20-40 years.
  • All patients suffering from extensor tendon injuries in zone 5 or 6.
  • All patients undergo extensor tendon repair surgery.
  • All patients will begin the treatment program from the third week post-operative.
  • All patients enrolled in the study will have their informed consent.

Who cannot join

  • The potential participants will be excluded if they meet one of the following criteria:
  • Patients with associated diseases (diabetes mellitus, infectious diseases, autoimmune disease) that will interfere with the healing process.
  • Patients taking medication that alters the healing process (e.g., corticosteroids, chemotherapy, or radiation).
  • Pregnancy or epilepsy.
  • Elderly patients.
  • Skin disease.

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Mansoura international hospital, Dakahlia government, Egypt

    Al Mansurah

Other trials in Egypt

About this study

The purpose of the study was to evaluate the effectiveness of dynamic hand splint on hand range of motion following extensor tendon repair.

Read the detailed description

The extensor muscles to the digits are weaker; their capacity for work and their amplitude of glide are less than those of their flexor antagonists, yet they require a latitude of motion that is not necessary for flexor function. Extensor tendons are thinner and broader than flexor tendons. They are superficial in comparison with the flexor tendons, allowing adhesion to the fascial layers and skin. They have a broad tendon-to-bone interface that can result in dense adhesions. Shortening of the extensor tendon because of surgery may result in difficulty regaining full flexion. Dorsal swelling may prevent the tendons from gliding. Recreating the normal balance between intrinsic and extrinsic muscle/tendon units can be a challenging task for surgeons and therapists following extensor tendon injury. Common functional complications include loss of flexion, extensor lag, and decreased grip strength. To prevent these complications, extensor tendon approaches, similar to flexor tendon approaches, have evolved to include controlled passive and active mobilization using a dynamic splint immediately following surgery

Being tested
customized dynamic hand splint, traditional treatment (first stage), traditional treatment (second and third stage)
Medical subject headings
Hapnes Boman Skeie syndrome

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • customized dynamic hand splintOther

    After 3 weeks of repair surgery, both groups were asked to take of the static splints, then the patients in group A (study group) were asked to wear customized dynamic hand splint daytime between sessions whole duration from third week post operative for 2 months till the end of the rehabilitation sessions, on the other hand the patients in group B (control group) were not asked to wear customized dynamic hand splint.

  • traditional treatment (first stage)Other

    All patients underwent a standardized rehabilitation program involving chair exercises. Key components included management of postoperative hand edema through distal-to-proximal massage to enhance tendon glide and range of motion; deep friction massage to reduce adhesions of postoperative scars; positive effects of massage therapy on hypertrophic and burn scar thickness; use of ultrasound on repaired tendons to minimize adhesions and promote healing; and gentle passive range of motion exercises for wrist and finger joints to gradually restore motion.

  • traditional treatment (second and third stage)Other

    This stage spanned two weeks following rehabilitation, during which all patients in both groups performed gentle stretching, active-assisted, and active free range of motion exercises to improve neuromuscular control and joint movements.

    This stage lasted one month, during which all patients engaged in active resisted range of motion, strengthening exercises, and functional training to restore muscle power and daily activity levels. Thera-band resistance training can improve muscle strength and functional fitness in older adults in community settings, serving as a safe and manageable physical activity that nursing staff can seamlessly integrate into daily routines.

Study groups in NCT07290348
Study groupRoleWhat they receive
dynamic hand splintExperimentalThis group included 20 patients suffering from cuts of the extensor tendon of their hand in zone 5 or 6 and underwent tendon repair surgery in this study. They wear a dynamic hand splint after 3 weeks post-operative for 2 months in addition to their conventional medical treatment and traditional care (dressing).
Receives: Other: customized dynamic hand splint; Other: traditional treatment (first stage); Other: traditional treatment (second and third stage)
conventional medical treatmentActive comparatorThis group included 20 patients suffering from cuts of the extensor tendon of their hand in zone 5 or 6 and underwent tendon repair surgery in this study. They, without wearing a dynamic hand splint, received their conventional medical treatment and traditional care (dressing).
Receives: Other: traditional treatment (first stage); Other: traditional treatment (second and third stage)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. assessment of wrist range of motion

    The study measured the range of motion of the wrist at three stages: prior to treatment, after one month, and at the end of the treatment. Patients were positioned sitting with their elbows on a table.

    An electronic goniometer was employed for the measurements, ensuring the wrist was neutral (0°) for extension assessments. For wrist extension, the forearm was pronated and the elbow fully extended, with the goniometer aligned with the lateral side of the ulna and the fifth metacarpal for accurate measurement

    Measured: at baseline and after 1 months and 2 months

Secondary outcomes (2)
  1. assessment of metacarpophalangeal joint range of motion

    The study measured the range of motion of the metacarpophalangeal joint of the fingers at three stages: prior to treatment, after one month, and at the end of the treatment.To measure the metacarpophalangeal joint, patients positioned their hands outside the table, while an electronic goniometer was aligned on the dorsal side of the metacarpal and proximal phalanx for accurate measurement.

    Measured: at baseline and after 1 months and 2 months

  2. assessment of interphalangeal joints' range of motion

    The study measured the range of motion of the proximal and distal interphalangeal joints of the fingers at three stages: prior to treatment, after one month, and at the end of the treatment.

    The measurement of proximal interphalangeal joints involved patients positioning their hands outside a table while an electronic goniometer was aligned on the dorsal side of the proximal and middle phalanx of the targeted finger. For Distal interphalangeal joints, the setup differed slightly, with alignment on the lateral side of the middle phalanx and distal phalanx of the targeted finger.

    Measured: at baseline and after 1 months and 2 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Dec 2025
  2. Study start1 Aug 2023
  3. Primary completion1 Dec 2024
  4. Study completion1 Jan 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
40 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07290348
Sponsor's protocol ID
Magdy-MSc
Status last verified
Dec 2025
First submitted
5 Dec 2025
Last updated
18 Dec 2025
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing customized dynamic hand splint, traditional treatment (first stage) and traditional treatment (second and third stage) in people with Splints and Range of Motion, run by Cairo University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 18 Dec 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

assessment of wrist range of motion (time frame: at baseline and after 1 months and 2 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Dec 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in